OXT and social phobia: However, there is a clear need for larger,well-designed clinical trials, and several trials are currently underway toinvestigate the therapeutic potential of OXT in patients with AVP-Deficiency.OXT is also being explored as a possible treatment option in psychiatricconditions such as autism spectrum disorder, borderline personality disorder,and social anxiety disorder, with controversial results so far.